Board Of Directors
Stacey Bonnell, MBA, RACPresident
Stacey is currently serving as Director of Regulatory Affairs for Johnson & Johnson DePuy Synthes; supporting Trauma / CMF & Biomaterials New Product Development & Front End Innovation. She brings extensive medical device experience, working with all classifications of products and life cycles. Her recent roles with Johnson and Johnson have included RA management with responsibility for Spinal orthopedic products, Regulatory Compliance managing Outreach and remediation, and most recently /continued oversight of Biomaterials platforms. Stacey has been actively involved with OSMA since 2005, with her Board appointment beginning in 2014. Stacey boasts that OSMA brings together comradery, policy-shaping and advocacy… which is the perfect blend for any Regulatory enthusiast.
Lisa has 18 years experience in the medical device field, working to bring all classifications of products to market and maintaining post-market compliance obligations. Her recent roles with Aesculap Inc., and Aesculap Implant Systems, LLC., have included RA management with over site and responsibility for the Spinal, Ortho, Neuro, and Surgical Specialty products. Lisa has actively worked with OSMA since 2007. In 2016, Lisa was appointed to the OSMA board as Secretary.
Lori is Director of Regulatory Affairs at Globus Medical, Inc. She has prior experience with Quality and Regulatory Affairs at Orthovita Inc., Kensey Nash Corporation and DSM Biomedical. Lori holds a Master of Science in Biology from Villanova University and a Bachelor of Science in Medical Technology from Rutgers University. Lori has been actively involved with OSMA since 2010 and served on the Board of OSMA as Secretary from 2011 thru 2015.
Sharon StarowiczPast President and Industry Representative, FDA Orthopaedic and Rehabilitation Devices Advisory Panel
Sharon Starowicz served as President of OSMA from 2011 - 2018 and was nominated as the Industry Representative to the FDA Orthopaedic and Rehabilitation Devices Advisory Panel in 2017. Sharon is the Director of Regulatory Policy Innovation, Global Orthopaedics, for Johnson & Johnson, where she is responsible for providing strategic regulatory guidance and expertise and, with a focus on the external environment, shaping the evolving global regulatory policies that impact the medical device industry. She has over 30 years of regulatory affairs experience, specializing in Class I, II and III orthopedic and spinal devices. Sharon is also a member of the AAOS Orthopaedic Device Forum.
Rodney Parker, Ph.D.Board Member
Dr. Parker is Senior Principal Scientist in the Instrument Division of Stryker Corporation. In this role, he is responsible for research on a variety of topics. He holds an undergraduate degree in medical technology, a master’s degree in biomedical engineering and a PhD in business. Dr. Parker worked in pharmaceutical toxicology research for 18 years before joining Stryker in 1995. At Stryker, he has functioned in the roles of microbiologist, Regulatory Affairs Manager, and Clinical Affair/Sciences Manager before assuming his current role. He is a current member for numerous ISO, ASTM, AAMI and Canadian Standards Association technical standards committees.
Natalie HeckBoard Member
Natalie has 30+ years in the Orthopedics industry with various positions in Regulatory Affairs (16yrs) and Quality Engineering (15yrs), including product lifecycle management from design to obsolescence. Natalie has been an OSMA member since 2011, and has participated on various task forces and committees.
Her current position with Zimmer Biomet is in Corporate Regulatory Affairs, covering policies, procedures, intelligence and training. Key roles include participation on OSMA, AdvaMed and global industry working groups; initiating corporate communications on regulatory policies and regulatory intelligence; creation and administration of regulatory procedures and intranet page.
Bradley HeilBoard Member
Bradley is a Director of Regulatory Affairs at Smith & Nephew, Inc., currently leading Smith & Nephew’s Regulatory Operations. He holds a Master of Science in Biomedical Engineering from the University of Kentucky and a MBA from the University of Memphis. Bradley has been actively involved with OSMA since 2016.